Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.
Nelke C, Schroeter CB, Barman S, Stascheit F, Masanneck L, Theissen L, Huntemann N, Walli S, Cengiz D, Dobelmann V, Vogelsang A, Pawlitzki M, Räuber S, Konen FF, Skripuletz T, Hartung HP, König S, Roos A, Meisel A, Meuth SG, Ruck T. Nelke C, et al. Among authors: hartung hp. EBioMedicine. 2024 Jul;105:105231. doi: 10.1016/j.ebiom.2024.105231. Epub 2024 Jul 2. EBioMedicine. 2024. PMID: 38959848 Free PMC article.
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Bennett JL, Aktas O, Rees WA, Smith MA, Gunsior M, Yan L, She D, Cimbora D, Pittock SJ, Weinshenker BG, Paul F, Marignier R, Wingerchuk D, Cutter G, Green A, Hartung HP, Kim HJ, Fujihara K, Levy M, Katz E, Cree BAC; N-MOmentum study investigators. Bennett JL, et al. Among authors: hartung hp. EBioMedicine. 2022 Dec;86:104321. doi: 10.1016/j.ebiom.2022.104321. Epub 2022 Nov 10. EBioMedicine. 2022. PMID: 36370634 Free PMC article. Clinical Trial.
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.
Räuber S, Willison A, Korsen M, Kölsche T, Golombeck KS, Plaack B, Schüller J, Huntemann N, Rolfes L, Schroeter CB, Nelke C, Regner-Nelke L, Förster M, Ringelstein M, Barnett MH, Hartung HP, Aktas O, Albrecht P, Ruck T, Melzer N, Meuth SG, Kremer D. Räuber S, et al. Among authors: hartung hp. Front Immunol. 2022 Dec 23;13:1037214. doi: 10.3389/fimmu.2022.1037214. eCollection 2022. Front Immunol. 2022. PMID: 36618356 Free PMC article.
SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.
Willison AG, Pawlitzki M, Lunn MP, Willison HJ, Hartung HP, Meuth SG. Willison AG, et al. Among authors: hartung hp. JAMA Neurol. 2024 Feb 1;81(2):179-186. doi: 10.1001/jamaneurol.2023.5208. JAMA Neurol. 2024. PMID: 38227318 Review.
Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice.
Theissen L, Schroeter CB, Huntemann N, Räuber S, Dobelmann V, Cengiz D, Herrmann A, Koch-Hölsken K, Gerdes N, Hu H, Mourikis P, Polzin A, Kelm M, Hartung HP, Meuth SG, Nelke C, Ruck T. Theissen L, et al. Among authors: hartung hp. Cells. 2024 Mar 14;13(6):508. doi: 10.3390/cells13060508. Cells. 2024. PMID: 38534352 Free PMC article.
Consensus quality indicators for monitoring multiple sclerosis.
Voigt I, Fischer S, Proschmann U, Konofalska U, Richter P, Schlieter H, Berger T, Meuth SG, Hartung HP, Akgün K, Ziemssen T. Voigt I, et al. Among authors: hartung hp. Lancet Reg Health Eur. 2024 Mar 29;40:100891. doi: 10.1016/j.lanepe.2024.100891. eCollection 2024 May. Lancet Reg Health Eur. 2024. PMID: 38585674 Free PMC article. Review.
Challenges in monitoring the quality of care in multiple sclerosis-authors' reply.
Voigt I, Fischer S, Proschmann U, Konofalska U, Richter P, Schlieter H, Berger T, Meuth SG, Hartung HP, Akgün K, Ziemssen T. Voigt I, et al. Among authors: hartung hp. Lancet Reg Health Eur. 2024 May 27;42:100951. doi: 10.1016/j.lanepe.2024.100951. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 38846424 Free PMC article. No abstract available.
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C, Dobelmann V, Theissen L, Pawlitzki M, Räuber S, Willison A, Vogelsang A, Marina AD, Hartung HP, Melzer N, Konen FF, Skripuletz T, Hentschel A, König S, Schweizer M, Stühler K, Poschmann G, Roos A, Stenzel W, Meisel A, Meuth SG, Ruck T. Schroeter CB, et al. Among authors: hartung hp. Acta Neuropathol. 2024 Jun 18;147(1):102. doi: 10.1007/s00401-024-02754-6. Acta Neuropathol. 2024. PMID: 38888758 Free PMC article.
1,132 results